Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.
Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines. Through its partnerships, the Genetic Medicines division is ...
Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...
Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen ...
By Julie Steenhuysen CHICAGO, Jan 6 (Reuters) - U.S. officials are building a case that ongoing measles outbreaks in South ...
In A Nutshell Three Brazilian supercentenarians survived COVID-19 in 2020 before vaccines existed, showing remarkably strong ...
WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the publication of its 2026 Trends and Insights Report. This annual analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback